Personas / Equipo Humano

José Ángel Alda Díez

Buscador de publicaciones

Publicaciones

  • Montañés-Rada, F., Gastaminza-Pérez, X., Catalá, M.A., Ruiz-Sanz, F., Ruiz-Lázaro, P.M., Herreros-Rodríguez, O., García-Giral, M., Ortiz-Guerra, J., Alda JA, Mojarro-Práxedes, D., Cantó-Díez, T., Mardomingo-Sanz, M.J., Sasot-Llevadot, J., Ibáñez-Bordas, R.M., Soto-López, A., Pàmies-Massana, M., Rey-Sánchez, F., Ferrin-Erdozáin, M., Graell-Bernal, M., Granada-Jiménez, O., Morey-Canyelles, J., Romera-Torrens, M. and Rubio-Morell, B..

    GEITDAH consensus on conduct disorders in children and adolescents

    REVISTA DE NEUROLOGIA . 61(4): 167-182.

  • Alda JA, Soutullo C, Ramos-Quiroga JA, Quintero J, Hervás A, Hernández-Otero I, Sans-Fitó A, Cardo-Jalón EC, Fernández-Jaén A, Fernández-Pérez M, Hidalgo-Vicario MI, Eddy-Ives LS and Sánchez J.

    Expert recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD).

    ACTAS ESPANOLAS DE PSIQUIATRIA . 42 Suppl: 1-16. Nº de citas: 7

  • Arango C, Giráldez M, Merchán-Naranjo J, Baeza I, Castro-Fornieles J, Alda JA, Martínez-Cantarero C, Moreno C, de Andrés P, Cuerda C, de la Serna E, Correll CU, Fraguas D and Parellada M.

    Second-generation antipsychotic use in children and adolescents: A six-month prospective cohort study in drug-naïve patients

    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY . 53(11): 1179-11904. Nº de citas: 67

    [doi:10.1016/j.jaac.2014.08.009]

  • Baeza I, de la Serna E, Calvo-Escalona R, Morer A, Merchán-Naranjo J, Tapia C, Martínez-Cantarero MC, Andrés P, Alda JA, Sánchez B, Arango C and Castro-Fornieles J.

    Antipsychotic use in children and adolescents: a 1-year follow-up study.

    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY . 34(5): 613-619. Nº de citas: 33

    [doi:10.1097/JCP.0000000000000190]

  • Montoya A, Quail D, Anand E, Cardo E, Alda JA and Escobar R.

    Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder, based on a pooled analysis.

    ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS . 6(1): 25-34.

    [doi:10.1007/s12402-013-0119-5]

  • Alda JA and Serrano E.

    Attention-Deficit Hyperactivity Disorder: Agreement between Clinical Impression and the SNAP-IV Screening Tool

    ACTAS ESPANOLAS DE PSIQUIATRIA . 41(2): 76-83. Nº de citas: 17

  • Perales J, Olaya B, Fernández A, Alonso J, Vilagut G, Forero CG, San L, Alda JA and Haro JM.

    Association of childhood adversities with the first onset of mental disorders in Spain: results from the ESEMeD project

    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY . 48(3): 371-384. Nº de citas: 9

    [doi:10.1007/s00127-012-0550-5]

  • Montoya A, Hernández S, Massana MP, Herreros O, Garcia-Giral M, Cardo E, Alda JA, Soutullo C, Fernández-Jaén A and Fuentes J.

    Evaluating Internet information on attention-deficit/hyperactivity disorder (ADHD) treatment: parent and expert perspectives.

    Education for health (Abingdon, England) . 26(1): 48-53.

    [doi:10.4103/1357-6283.112801]

  • Serrano E, Guidi M and Alda JA.

    Is psychological treatment efficacious for attention deficit hyperactivity disorder (ADHD)? Review of non-pharmacological treatments in children and adolescents with ADHD

    ACTAS ESPANOLAS DE PSIQUIATRIA . 41(1): 44-51. Nº de citas: 26

  • Merchán-Naranjo J, Tapia C, Bailón C, Moreno C, Baeza I, Calvo-Escalona R, Morer A, Martínez-Cantarero C, Nestares PA, Alda JA, Muñoz D and Arango C.

    Secondary effects of antipsychotic treatment in naive or quasi-naive children and adolescents: Design of a follow-up protocol and baseline results

    Spanish journal of psychiatry and mental health . 5(4): 217-228. Nº de citas: 15

    [doi:10.1016/j.rpsm.2012.03.006]